Data Regarding Abraxane, Gemcitabine Plus Nivolumab Combo Study In Pancreatic Cancer

Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses Data Regarding Abraxane, Gemcitabine Plus Nivolumab Combo Study In Pancreatic Cancer. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com